Rankings
▼
Calendar
ZTS Q1 2017 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
+5.9% YoY
Gross Profit
$767M
62.3% margin
Operating Income
$368M
29.9% margin
Net Income
$238M
19.3% margin
EPS (Diluted)
$0.48
QoQ Revenue Growth
-3.6%
Cash Flow
Operating Cash Flow
$119M
Free Cash Flow
$77M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$7.6B
Total Liabilities
$6.0B
Stockholders' Equity
$1.6B
Cash & Equivalents
$629M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.2B
+5.9%
Gross Profit
$767M
$773M
-0.8%
Operating Income
$368M
$347M
+6.1%
Net Income
$238M
$204M
+16.7%
Revenue Segments
Dogs and Cats
$482M
40%
Cattle
$386M
32%
Swine
$160M
13%
Poultry
$116M
10%
Horses
$35M
3%
Fish
$21M
2%
Sheep and Other
$20M
2%
Geographic Segments
International
$615M
50%
UNITED STATES
$605M
50%
← FY 2017
All Quarters
Q2 2017 →